What's new

Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 22, Status: Authorised

Mar 6, 2025 - 13:40
 0
Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 22, Status: Authorised
Read More

Tags:

Previous Article

Merck KGaA fails midphase lupus trial, says totality of data support further dev...

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Vimpat, lacosamide, d...

Related Posts

Herbal medicinal product: Anisi aetheroleumArray, F: Assessment finalised

Herbal medicinal product: Anisi aetheroleumArray, F: As...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 6, 2025  0

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0